BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8182006)

  • 21. Artificial infections of Pneumocystis carinii in the SCID mouse and their use in the in vivo evaluation of antipneumocystis drugs.
    Comley JC; Sterling AM
    J Eukaryot Microbiol; 1994; 41(6):540-6. PubMed ID: 7866380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pneumocystis carinii pneumonia].
    Szabados A; Schierz G; Deinhardt F
    Internist (Berl); 1985 Jun; 26(6):335-40. PubMed ID: 3897099
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of Pneumocystis carinii pneumonitis. A comparative trial of sulfamethoxazole-trimethoprim v pentamidine in pediatric patients with cancer: report from the Children's Cancer Study Group.
    Siegel SE; Wolff LJ; Baehner RL; Hammond D
    Am J Dis Child; 1984 Nov; 138(11):1051-4. PubMed ID: 6388315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
    N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid therapy for severe Pneumocystis carinii pneumonia.
    Miller RF; Semple SJ
    J Infect; 1990 Sep; 21(2):131-7. PubMed ID: 2230171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of trimetrexate, a potent lipid-soluble antifolate, in the treatment of rodent Pneumocystis carinii pneumonia.
    Kovacs JA; Allegra CJ; Kennedy S; Swan JC; Drake J; Parrillo JE; Chabner B; Masur H
    Am J Trop Med Hyg; 1988 Nov; 39(5):491-6. PubMed ID: 2973755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii.
    Hughes WT
    Antimicrob Agents Chemother; 1979 Sep; 16(3):333-5. PubMed ID: 315754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.
    Boylan CJ; Current WL
    Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumatoceles in pneumocystic carinii pneumonia of AIDS and low dose trimethoprim-sulphamethoxazole therapy.
    Rosha D; Dandona PK
    J Assoc Physicians India; 1995 Sep; 43(9):635-7. PubMed ID: 8773069
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of semiquantitative PCR to assess onset and treatment of Pneumocystis carinii infection in rat model.
    O'Leary TJ; Tsai MM; Wright CF; Cushion MT
    J Clin Microbiol; 1995 Mar; 33(3):718-24. PubMed ID: 7751383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified trimethoprim-sulphamethoxazole doses in Pneumocystis carinii pneumonia.
    McLean I; Lucas CR; Mashford ML; Harman PJ
    Lancet; 1987 Oct; 2(8563):857-8. PubMed ID: 2889058
    [No Abstract]   [Full Text] [Related]  

  • 32. Secondary Pneumocystis carinii pneumonia prophylaxis with trimethoprim-sulphamethoxazole does not prevent bacterial pneumonia in HIV-infected persons.
    Tumbarello M; Tacconelli E; Cauda R; Ortona L
    AIDS; 1996 Nov; 10(13):1603-4. PubMed ID: 8931803
    [No Abstract]   [Full Text] [Related]  

  • 33. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
    Morris-Jones SD; Easterbrook PJ
    J Antimicrob Chemother; 1997 Sep; 40(3):315-8. PubMed ID: 9338481
    [No Abstract]   [Full Text] [Related]  

  • 34. [An animal model of Pneumocystis carinii pneumonia and therapeutic efficacy of interferon-gamma in this model].
    Nakamoto A; Kitsukawa K; Ishimine T; Inadome J; Kusano N; Fukuhara H; Saito A
    Kansenshogaku Zasshi; 1993 Oct; 67(10):971-7. PubMed ID: 8254217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole.
    Hughes WT; Feldman S; Sanyal SK
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):47-50. PubMed ID: 1079469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of gallium67 scintigraphy and bronchial washings in the diagnosis and treatment of Pneumocystis carinii pneumonia in patients with the acquired immune deficiency syndrome.
    Tuazon CU; Delaney MD; Simon GL; Witorsch P; Varma VM
    Am Rev Respir Dis; 1985 Nov; 132(5):1087-92. PubMed ID: 3877481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia.
    Dorr RT; Powell JR; Heick M; Barry DW
    Postgrad Med J; 1981 Feb; 57(664):123-5. PubMed ID: 6973756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug treatment of pneumonia due to Pneumocystis carinii.
    Huffman D; Musher DM; Reuben AG
    Tex Med; 1987 Feb; 83(2):27-30. PubMed ID: 3493548
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of pneumocystis carinii pneumonia in children.
    Lipson A; Marshall WC; Hayward AR
    Arch Dis Child; 1977 Apr; 52(4):314-9. PubMed ID: 301010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist.
    Hughes WT; Jacobus DP; Canfield C; Killmar J
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1417-9. PubMed ID: 8363369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.